LABORATORY RESEARCH Mutual Regulation between Raf/MEK/ERK Signaling and Y-Box-Binding Protein-1 Promotes Prostate Cancer Progression Researchers examined the interaction between Y-box-binding protein-1 (YB-1) and the mitogen-activated protein kinase pathway in prostate cancer. Epidermal-growth factor up-regulated phosphorylated YB-1 (p-YB-1), while MEK inhibitor decreased p-YB-1. Inversely, silencing of YB-1 using small-interfering RNA decreased the expression of ERK2, and phosphorylated MEK, ERK1/2, and RSK. [Clin Cancer Res] Abstract DNA Methylation and Nucleosome Occupancy Regulate the Cancer Germline Antigen Gene MAGEA11 In prostate and epithelial ovarian cancers, MAGEA11 expression was associated with promoter and global DNA hypomethylation, and with activation of other cancer germline genes. Pharmacological or genetic inhibition of DNA methyltransferases and/or histone deacetylases activated MAGEA11 in a cell line specific manner. [Epigenetics] Abstract Surface CD24 Distinguishes between Low Differentiated and Transit-Amplifying Cells in the Basal Layer of Human Prostate Scientists examined the role of surface markers to distinguish between different subsets of prostate basal epithelium. Subsets with distinct differentiation capacities within the basal epithelium can be distinguished in human prostate. [Prostate] Abstract Targeted Induction of Endogenous NKX3-1 by Small Activating RNA Inhibits Prostate Tumor Growth Researchers used small activating RNA (saRNA) as a molecular tool to examine NKX3-1‘s role as a tumor suppressor and tested in vitro and in vivo antitumor effects of NKX3-1 induction by saRNA. NKX3-1 saRNA induced NKX3-1 expression in different prostate cancer cell lines, resulting in inhibited cell proliferation and survival, cell cycle arrest and apoptotic cell death. [Prostate] Abstract Repression of NR4A1 by a Chromatin Modifier Promotes Docetaxel Resistance in PC-3 Human Prostate Cancer Cells Scientists report the upregulated expression of metastasis-associated protein 1 (MTA1), a component of the nucleosome remodeling deacetylation complex, in chemoresistant prostate cancer. MTA1 knockdown in PC-3 cells inhibited cell proliferation and enhanced docetaxel-induced cell death. [FEBS Lett] Abstract Anterograde Trafficking of CXCR4 and CCR2 Receptors in a Prostate Cancer Cell Line PC3 prostate cancer cells were used to demonstrate the importance of various Rab GTPases on cell surface expression and signaling of CXCR4 and CCR2, along with the CXCR4/CCR2 heterodimer. Rab GTPases required for cell surface expression and signal transduction of CXCR4 or CCR2 differ from those required for the CXCR4/CCR2 heterodimer. [Cell Physiol Biochem] Full Article Aromatic Hydrocarbon Receptor Inhibits Lysophosphatidic Acid-Induced Vascular Endothelial Growth Factor-A Expression in PC-3 Prostate Cancer Cells Scientists first confirmed the ability of lysophosphatidic acid (LPA) to induce vascular endothelial growth factor-A (VEGF-A) expression in PC-3 cells and then validated that LPA-induced VEGF-A expression was regulated by hypoxia-inducible factor-1a and aromatic hydrocarbon receptor nuclear translocator through phosphatidylinositol 3-kinase activation. [Biochem Biophys Res Commun] Full Article Epithelial-Mesenchymal Transition and Migration of Prostate Cancer Stem Cells Is Driven by Cancer-Associated Fibroblasts in an HIF-1a/ß-Catenin-Dependent Pathway Scientists first comparatively analyzed a series of prostate cancer stem cells, which exhibited a dynamically increasing and disseminating ability in nude mice. They observed that the transcriptional activity of HIF-1a and ß-catenin became gradually elevated in these stem cells and their epithelial-mesenchymal transition characteristic altered from an epithelial type to a mesenchymal type. [Mol Cells] Abstract The Effect of LHRH Antagonist Cetrorelix in Crossover Conditioned Media from Epithelial (BPH-1) and Stromal (WPMY-1) Prostate Cells Investigators evaluated the effects of crossover conditioned media (CM) of stromal and epithelial prostate cells before and after treatment with LHRH antagonist Cetrorelix. CM from WPMY-1 cells strongly stimulated the proliferation of BPH-1 cells in a dose dependent manner, while CM from BPH-1 cells only slightly increased the proliferation of WPMY-1 cells. [Horm Metab Res] Abstract CLINICAL RESEARCH Effect of Soy Protein Isolate Supplementation on Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy The authors determined whether daily consumption of a soy protein isolate supplement for two years reduces the rate of biochemical recurrence of prostate cancer after radical prostatectomy or delays such recurrence. Daily consumption of a beverage powder supplement containing soy protein isolate for two years following radical prostatectomy did not reduce biochemical recurrence of prostate cancer in men at high risk of prostate-specific antigen failure. [JAMA] Abstract | Press Release Arylsulfatase B (N-Acetylgalactosamine-4-Sulfatase): Potential Role As a Biomarker in Prostate Cancer Arylsulfatase B (ARSB) immunostaining was performed on two tissue microarrays and analyzed by digital image analysis, generating ARSB H-scores for prevalence and intensity of epithelial, stromal and combined epithelial and stromal immunostaining. Forty-four cases of prostate cancer were paired by age, race, Gleason score and pathological tumor, node, metastasis score. The pairs differed by recurrence vs non-recurrence of elevated PSA at = 4 years. [Prostate Cancer P D] Abstract |